share_log
Reuters ·  Mar 17 11:05
Travere Therapeutics Inc: FDA Notified Company That Rems Monitoring for Embryo-Fetal Toxicity Is No Longer Necessary
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 328

Recommended

Write a comment